Home > Insider Trading > Filing (0001567619-21-011727)

Filing Details

Accession Number:: 0001567619-21-011727
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2021-06-04 17:41:09
Reporting Period:: 2021-06-02

Accepted Time:: 2021-06-04 17:41:09
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1819810	Genesis Park Acquisition Corp.	GNPK	()	DE

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1629984	Crescent Park Management, L.p.	1900 University Avenue, Suite 501 East Palo Alto CA 94303		No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Class A Ordinary Shares	Acquisiton	2021-06-02	7,859	$10.04	2,554,984	No	4	P	Indirect	See Notes 1 and 2

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	See Notes 1 and 2

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Warrant	Equity Swap (obligation to buy)	Acquisiton	2021-06-02	1	$0.00	4,330	$1.57

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
1	2023-06-01	2023-06-01	Yes	4	J	Indirect

Footnotes

The reporting persons are Crescent Park Management, L.P. ("Crescent Park"), Crescent Park GP, LLC ("Crescent Park GP") and Eli D. Cohen. Crescent Park is the investment adviser of investment funds (the "Funds"), and Crescent Park GP is the general partner of the Funds. Mr. Cohen is the control person of Crescent Park and Crescent Park GP. Crescent Park is filing this report for itself and the other reporting persons. The reporting persons are filing this Form 4 jointly, but not as a group, and each expressly disclaims membership in a group within the meaning of Rule 13d-5(b) under the Securities Exchange Act of 1934.
The Funds hold the securities reported herein directly for the benefit of their investors. Crescent Park and Crescent Park GP indirectly beneficially own the securities reported herein as the investment adviser and general partner, respectively, of the Funds. Mr. Cohen indirectly beneficially owns the securities reported herein as the control person of Crescent Park and Crescent Park GP. The reporting persons disclaim beneficial ownership of such securities except to the extent of their pecuniary interest in them.
On June 2, 2021, the reporting persons entered into an equity swap agreement with a securities broker under which, upon expiration of the two-year term of agreement, either (1) the broker will be required to pay to the reporting persons an amount representing the price of a warrant of the Issuer at the time of expiration, less $1.5696, multiplied by 4,330 warrants, less accrued broker financing charges or (2) the reporting persons will be required to pay to the broker an amount representing $1.5696 less the price of a warrant of the Issuer at the time of expiration, multiplied by 4,330 warrants, plus accrued broker financing charges.
Each warrant entitles the holder to purchase one Class A ordinary share of the Issuer at a price of $11.50 per share, becomes exercisable on the later of 30 days after the completion of the Issuer's initial business combination and November 27, 2021, and expires five years after the completion of the Issuer's initial business combination or earlier upon redemption of the warrants or liquidation of the Issuer.